文献速递急性肾损伤

远程缺血预适应对体外循环心脏手术成人患者肾脏和心脏保护作用的系统综述与荟萃分析

Remote ischaemic preconditioning for renal and cardiac protection in adult patients undergoing cardiac surgery with cardiopulmonary bypass: systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

整体分析显示RIPC未显著降低急性肾损伤、心肌梗死、房颤、死亡率或ICU及住院时间,但显著降低心肌损伤生物标志物曲线下面积和复合终点发生率。仅在挥发性麻醉药亚组中,RIPC显著降低急性肾损伤发生率和复合终点。

要点

  • 整体人群中RIPC未显著降低AKI、心梗、房颤、死亡率或住院时间。
  • RIPC显著降低心肌损伤生物标志物曲线下面积(SMD -0.37)。
  • 仅挥发性麻醉药亚组中RIPC显著降低AKI发生率(OR 0.57)。

核心结论

  • RIPC在体外循环心脏手术成人患者中未一致降低发病率和死亡率。
  • 仅在挥发性麻醉药亚组中,RIPC显著降低AKI发生率、复合终点及心肌损伤。

研究设计与样本

  • 采用随机效应模型分析标准化均数差(SMD)和Peto比值比(OR),预先计划亚组分析评估不同麻醉方案的影响。

主要发现

  • 整体组中RIPC未显著降低急性肾损伤、急性心肌梗死、心房颤动、死亡率或ICU及住院时间。
  • RIPC显著降低心肌损伤生物标志物曲线下面积(SMD -0.37,95%CI -0.53至-0.21)。
  • RIPC显著降低复合终点发生率(OR 0.85,95%CI 0.74-0.97)。
  • 挥发性麻醉药组中RIPC显著降低AKI发生率(OR 0.57,95%CI 0.41-0.79),并边缘性降低ICU停留时间。
  • 丙泊酚(联合或不联合挥发性麻醉药)组中,除心肌损伤生物标志物外,RIPC效果较少且不显著。

临床怎么用

  • 在体外循环心脏手术成人患者中,RIPC整体肾脏保护作用不确切,不应常规用于所有患者。
  • 若采用挥发性麻醉药,RIPC可能显著降低AKI发生率和复合终点,可考虑在此亚组中应用。

局限性

  • 原文未明确报告纳入试验的偏倚风险、异质性或发表偏倚等局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The main aim of this systematic review was to assess whether remote ischaemic preconditioning (RIPC) protects kidneys and the heart in cardiac surgery with cardiopulmonary bypass (CPB) and to investigate a possible role of anaesthetic agents. METHODS: Randomized clinical trials (RCTs) on the effects of RIPC through limb ischaemia in adult patients undergoing cardiac surgery with CPB were searched (1965-October 2016) in PubMed, Cochrane Library and article reference lists. A random effects model on standardized mean difference (SMD) for continuous outcomes and the Peto odds ratio (OR) for dichotomous outcomes were used to meta-analyse data. Subgroup analyses to evaluate the effects of different anaesthetic regimens were pre-planned. RESULTS: Thirty-three RCTs (5999 participants) were included. In the whole group, RIPC did not significantly reduce the incidence of acute kidney injury (AKI), acute myocardial infarction, atrial fibrillation, mortality or length of intensive care unit (ICU) and hospital stays. On the contrary, RIPC significantly reduced the area under the curve for myocardial injury biomarkers (MIBs) {SMD -0.37 [95% confidence interval (CI) -0.53 to - 0.21]} and the composite endpoint incidence [OR 0.85 (95% CI 0.74-0.97)]. In the volatile anaesthetic group, RIPC significantly reduced AKI incidence [OR 0.57 (95% CI 0.41-0.79)] and marginally reduced ICU stay. Conversely, except for MIBs, RIPC had fewer non-significant effects under propofol with or without volatile anaesthetics. CONCLUSIONS: RIPC did not consistently reduce morbidity and mortality in adults undergoing cardiac surgery with CPB. In the subgroup on volatile anaesthetics only, RIPC markedly and significantly reduced the incidence of AKI and composite endpoint as well as myocardial injury.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Deferrari G, Bonanni A, Bruschi M, et al. Remote ischaemic preconditioning for renal and cardiac protection in adult patients undergoing cardiac surgery with cardiopulmonary bypass: systematic review and meta-analysis of randomized controlled trials. Nephrol Dial Transplant. 2018. PMID: 28992285. doi:10.1093/ndt/gfx210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。